全部

1·Specifically disclosed is an ataractic agent comprising a vitamin K as an active ingredient.

本发明的镇定剂含有作为活性成分的维生素k。

2·Also specifically disclosed is a supplement, health food or functional food for ataractic purposes, which comprises a vitamin K as an active ingredient.

本发明还提供了一种用于镇定目的的、含有维生素k作为活性成分的补充物、保健食品或功能性食品。

3·Results 95 patients with LVAS had audition hurt when they were admitted in hospital. Among them, 36 patients were deaf-and-dumb and 2 children 'data were not collected because they took ataractic.

结果95例LVAS患者就诊时听力均受损，其中36例无听力呈聋哑状态，2例儿童服镇静药，没有收集到听力资料。